TRVI insider trading
Open-market stock trades by Trevi Therapeutics (TRVI) executives and directors: who bought or sold, how many shares, at what price and when.
TRVI insider trades
| Date | Insider | Role | Trade | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Heffernan Michael Thomas | director | Sell | 20,952 | $15.09 | $316.17K |
| Sep 15, 2026 | Heffernan Michael Thomas | director | Sell | 100 | $15.88 | $1.59K |
| Mar 25, 2025 | SCIASCIA THOMAS | Chief Scientific Officer | Sell | 2,631 | $6.60 | $17.36K |
| Mar 21, 2025 | GOOD JENNIFER L | President & CEO | Sell | 5,263 | $6.58 | $34.62K |
| Mar 10, 2025 | Simon Farrell | Chief Commercial Officer | Sell | 76,963 | $6.73 | $517.78K |
| Mar 10, 2025 | Simon Farrell | Chief Commercial Officer | Sell | 4,350 | $7.15 | $31.10K |
| Sep 6, 2024 | GOOD JENNIFER L | President & CEO | Sell | 4,219 | $3.03 | $12.78K |
| Sep 9, 2024 | GOOD JENNIFER L | President & CEO | Sell | 1,840 | $3.04 | $5.59K |
| Sep 3, 2024 | GOOD JENNIFER L | President & CEO | Sell | 3,863 | $3.02 | $11.68K |
| Sep 4, 2024 | GOOD JENNIFER L | President & CEO | Sell | 10,981 | $3.02 | $33.21K |
| Sep 5, 2024 | GOOD JENNIFER L | President & CEO | Sell | 40,277 | $3.11 | $125.31K |
- TRVI insiders bought $0.00 and sold $1.11M in open-market trades over their last 11 filings.
Updated 2026-11-02 23:13 UTC